JamesWilliamWelshMD

Radiation Oncology • Houston, TX

Physician

Join to view full profile

Dr. Welsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Welsh's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of Arizona College of Medicine-TucsonResidency, Radiation Oncology, 2004 - 2008
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Internal Medicine, 2003 - 2004
Geisel School of Medicine at DartmouthClass of 2003

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2008 - 2025
OK State Medical License 2020 - 2021
American Board of Radiology Radiation Oncology

Clinical Trials

Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer Start of enrollment: 2009 Mar 26
Completed
Phase 2
Simultaneous Integrated Boost (SIB) in Esophageal Cancer Start of enrollment: 2010 Apr 01
Completed
Phase 1
Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) Start of enrollment: 2014 Jun 01
Withdrawn
Phase 1, Phase 2
Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors Start of enrollment: 2014 Aug 26
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
Matthew S Ning, Abigael Odwuor, Joe Y Chang, Saumil Gandhi, Zhongxing Liao
Cancers. 2024-10-24
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies.
Joe Y Chang, Xinyan Xu, Girish S Shroff, Nathan I Comeaux, Wei Li
Journal for Immunotherapy of Cancer. 2024-10-09
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.
Yun Hu, Sébastien Paris, Narayan Sahoo, Qi Wang, Qianxia Wang
Journal of Nanobiotechnology. 2024-10-01

Lectures

Randomized phase I/II trial of pembrolizumab with and without radiotherapy for metastatic non-small cell lung cancer.
2019 ASCO Annual Meeting - 6/1/2019